<DOC>
	<DOCNO>NCT01146171</DOCNO>
	<brief_summary>The purpose clinical study evaluate safety tolerability CT-322 monotherapy determine recommend dose phase II subsequent study</brief_summary>
	<brief_title>Japanese Phase 1 Study BMS-844203 ( CT322 )</brief_title>
	<detailed_description />
	<criteria>Advanced metastatic solid tumor standard care ineffective inappropriate Life expectancy least 3 month Eastern Cooperative Oncology Group performance 01 Subject uncontrolled diabetes hypertension Clinical significant bleeding diathesis coagulopathy Thrombotic embolic cerebrovascular accident</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>